{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T20:13:47Z","timestamp":1697055227890},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1016\/j.diagmicrobio.2004.02.001","type":"journal-article","created":{"date-parts":[[2004,5,11]],"date-time":"2004-05-11T10:36:08Z","timestamp":1084271768000},"page":"53-58","source":"Crossref","is-referenced-by-count":6,"title":["Antimicrobial susceptibility patterns of Streptococcus pneumoniae in Mexico"],"prefix":"10.1016","volume":"49","author":[{"given":"Francisco","family":"Qui\u00f1ones-Falconi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Jos\u00e9","family":"Calva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yolanda","family":"L\u00f3pez-Vidal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Galicia-Velazco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Elena","family":"Jim\u00e9nez-Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"Larios-Mondrag\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2004.02.001_BIB1","doi-asserted-by":"crossref","unstructured":"American Thoracic Society Official Statement (2001). Guidelines for the management of adults with community-acquired pneumonia, diagnosis, assessment of severity, antimicrobial therapy and prevention. Am J Respir Crit Care Med 163:1730\u20131754","DOI":"10.1164\/ajrccm.163.7.at1010"},{"key":"10.1016\/j.diagmicrobio.2004.02.001_BIB2","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1086\/313954","article-title":"Practice guidelines for the management of community-acquired pneumonia in adults","volume":"31","author":"Bartlett","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2004.02.001_BIB3","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0022-3476(98)70510-4","article-title":"Breakthrough bacteremia and meningitis during treatment parenterally with cephalosporins for pneumococcal pneumonia","volume":"132","author":"Buckingham","year":"1998","journal-title":"J Pediatr"},{"key":"10.1016\/j.diagmicrobio.2004.02.001_BIB4","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1086\/516340","article-title":"Clinical outcome of invasive infections by penicillin-resistant Streptococcus pneumoniae in Korean Children","volume":"6","author":"Choi","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2004.02.001_BIB5","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1542\/peds.103.2.409","article-title":"Risk factors and course of illness among children with invasive penicillin-resistant Streptococcus pneumoniae","volume":"103","author":"Deeks","year":"1999","journal-title":"Pediatrics"},{"key":"10.1016\/j.diagmicrobio.2004.02.001_BIB6","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1128\/AAC.45.6.1721-1729.2001","article-title":"Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999\u20132000, including a comparison of resistance rates since 1994\u20131995","volume":"45","author":"Doern","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2004.02.001_BIB7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00006454-199901000-00002","article-title":"Acute otitis media. Management and surveillance in an era of pneumococcal resistance. A report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group","volume":"18","author":"Dowell","year":"1999","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.diagmicrobio.2004.02.001_BIB8","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1086\/588389","article-title":"Pneumonia treatment failure associated with highly resistant pneumococci","volume":"29","author":"Dowell","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2004.02.001_BIB9","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1089\/mdr.1998.4.241","article-title":"Predominance of the multiresistant 23F international clone of Streptococcus pneumoniae among isolates from Mexico","volume":"4","author":"Echaniz-Aviles","year":"1998","journal-title":"Microbiol Drug Resist"},{"key":"10.1016\/j.diagmicrobio.2004.02.001_BIB10","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2105\/AJPH.90.2.223","article-title":"Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995\u20131997","volume":"90","author":"Feikin","year":"2000","journal-title":"Am J Public Health"},{"key":"10.1016\/j.diagmicrobio.2004.02.001_BIB11","doi-asserted-by":"crossref","unstructured":"Felmingham D, Washington J, The Alexander Project Group (1999). Trends in the antimicrobial susceptibility of bacterial respiratory tract pathogens. Findings of the Alexander Project 1992\u20131996. J Chemother 11:5\u201321","DOI":"10.1179\/joc.1999.11.Supplement-2.5"},{"key":"10.1016\/j.diagmicrobio.2004.02.001_BIB12","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1097\/00006454-199510000-00013","article-title":"Comparison of the response to antimicrobial therapy of penicillin-resistant and penicillin-susceptible pneumococcal disease","volume":"14","author":"Friedland","year":"1995","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.diagmicrobio.2004.02.001_BIB13","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1001\/archinte.160.10.1399","article-title":"Management of community-acquired pneumonia in the era of pneumococcal resistance","volume":"160","author":"Heffelfinger","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.diagmicrobio.2004.02.001_BIB14","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/jac\/48.5.659","article-title":"Increasing resistance of Streptococcus pneumoniae to fluoroquinolones","volume":"48","author":"Ho","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2004.02.001_BIB15","doi-asserted-by":"crossref","unstructured":"Hoban DJ, Doern GV, Fluit AC, Roussel-Delvallez M, Jones RN (2001). Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997\u20131999. Clin Infect Dis 32:S81\u2013S93","DOI":"10.1086\/320181"},{"key":"10.1016\/j.diagmicrobio.2004.02.001_BIB16","doi-asserted-by":"crossref","unstructured":"Jacobs MR (1999). Drug-resistant Streptococcus pneumoniae: Rational antibiotic choices. Am J Med 106:19S\u201325S","DOI":"10.1016\/S0002-9343(98)00351-9"},{"key":"10.1016\/j.diagmicrobio.2004.02.001_BIB17","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1086\/341980","article-title":"In vivo veritas","volume":"35","author":"Jacobs","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2004.02.001_BIB18","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0924-8579(00)00193-X","article-title":"Susceptibility of 1100 Streptococcus pneumoniae strains isolated in 1997 from seven Latin American and Caribbean countries","volume":"16","author":"Jacobs","year":"2000","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.diagmicrobio.2004.02.001_BIB19","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1128\/AAC.43.8.1901","article-title":"Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 oral antimicrobial agents based on pharmacodynamic parameters","volume":"43","author":"Jacobs","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2004.02.001_BIB20","unstructured":"Jacobs MR, Weinberg W (2001). Evidence-based guidelines for treatment of bacterial respiratory tract infections in the era of antibiotic resistance. Managed Care Interface April, 68\u201380"},{"key":"10.1016\/j.diagmicrobio.2004.02.001_BIB21","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/jac\/44.4.425","article-title":"Will pneumococci put quinolones in their place?","volume":"44","author":"Legg","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2004.02.001_BIB22","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1086\/341978","article-title":"Failure of macrolide antibiotic treatment in patients with bacteremia due to erythromycin-resistant Streptococcus pneumoniae","volume":"35","author":"Lonks","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2004.02.001_BIB23","series-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically","year":"2003"},{"key":"10.1016\/j.diagmicrobio.2004.02.001_BIB24","series-title":"Performance standards for antimicrobial susceptibility testing","year":"2003"},{"key":"10.1016\/j.diagmicrobio.2004.02.001_BIB25","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1056\/NEJM199508243330802","article-title":"Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain","volume":"333","author":"Pallares","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diagmicrobio.2004.02.001_BIB26","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1128\/AAC.46.8.2665-2667.2002","article-title":"Activities of six different quinolones against clinical respiratory isolates of Streptococcus pneumoniae with reduced susceptibility to ciprofloxacin in Spain","volume":"46","author":"Perez-Trallero","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2004.02.001_BIB27","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0732-8893(02)00446-7","article-title":"Gatifloxacin Phase IV Surveillance Trial (TeqCES Study) utilizing 5000 primary care physician practices","volume":"44","author":"Pfaller","year":"2002","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2004.02.001_BIB28","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1056\/NEJM200207043470115","article-title":"Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia","volume":"347","author":"Ross","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diagmicrobio.2004.02.001_BIB29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1067\/mhn.2000.107873","article-title":"Antimicrobial treatment guidelines for acute bacterial rhinosinusitis","volume":"123","year":"2000","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.diagmicrobio.2004.02.001_BIB30","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1086\/520209","article-title":"Penicillin resistance and other predictors of mortality in pneumococcal bacteremia in a population with high HIV seroprevalence","volume":"29","author":"Turett","year":"1999","journal-title":"Clin Infect Dis"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889304000288?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889304000288?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T03:38:59Z","timestamp":1585798739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889304000288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["S0732889304000288"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2004.02.001","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2004,5]]}}}